Ouabain affects the expression of activation markers, cytokine production, and endocytosis of human monocytes

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Teixeira, Mariana Pires ^a   Rumjanek, Vivian Mary ^a  

^a Laboratório de Imunologia Tumoral Instituto de Bioquímica Médica Leopoldo de Meis H2 003 Cidade Universitária   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CALCIUM; CD40 ANTIGEN; CD69 ANTIGEN; CD86 ANTIGEN; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; OUABAIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; CYTOKINE; ENZYME INHIBITOR; LECTIN; LEUKOCYTE ANTIGEN; T LYMPHOCYTE ANTIGEN;

ADULT; ANTIGEN PRESENTATION; ARTICLE; CALCIUM CELL LEVEL; CELL ACTIVATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDOCYTOSIS; HUMAN; HUMAN CELL; MIXED LYMPHOCYTE REACTION; MONOCYTE; NORMAL HUMAN; PROTEIN EXPRESSION; T LYMPHOCYTE; UPREGULATION; BLOOD; CYTOLOGY; DRUG EFFECTS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; METABOLISM; MIXED LYMPHOCYTE CULTURE; MONONUCLEAR CELL; PATHOLOGY;

ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CYTOKINES; ENDOCYTOSIS; ENZYME INHIBITORS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HEALTHY VOLUNTEERS; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-1BETA; LECTINS, C-TYPE; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE CULTURE TEST, MIXED; MONOCYTES; OUABAIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84901817611     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/760368     Document Type: Article

References (38)

1. Schoner W., Endogenous cardiac glycosides, a new class of steroid hormones. European Journal of Biochemistry 2002 269 10 2440 2448 2-s2.0-0036106788 10.1046/j.1432-1033.2002.02911.x (Pubitemid 34539271)
2. Hamlyn J. M., Blaustein M. P., Bova S., DuCharme D. W., Harris D. W., Mandel F., Mathews W. R., Ludens J. H., Identification and characterization of a ouabain-like compound from human plasma. Proceedings of the National Academy of Sciences of the United States of America 1991 88 6259 6263 (Pubitemid 21914926)
3. Antolovic R., Bauer N., Mohadjerani M., Kost H., Neu H., Kirch U., Grunbaum E.-G., Schoner W., Endogenous ouabain and its binding globulin: effects of physical exercise and study on the globulin's tissue distribution. Hypertension Research 2000 23, supplement S93 S98 2-s2.0-0033799467
4. Gottlieb S. S., Rogowski A. C., Weinberg M., Krichten C. M., Hamilton B. P., Hamlyn J. M., Elevated concentrations of endogenous ouabain in patients with congestive heart failure. Circulation 1992 86 2 420 425 2-s2.0-0026637052
5. Bauer N., Müller-Ehmsen J., Krämer U., Hambarchian N., Zobel C., Schwinger R. H. G., Neu H., Kirch U., Grünbaum E.-G., Schoner W., Ouabain-like compound changes rapidly on physical exercise in humans and dogs: effects of β -blockade and angiotensin-converting enzyme inhibition. Hypertension 2005 45 5 1024 1028 2-s2.0-20944451171 10.1161/01.HYP.0000165024. 47728.f7 (Pubitemid 40628954)
6. Goto A., Yamada K., Nagoshi H., Terano Y., Omata M., Stress-induced elevation of ouabainlike compound in rat plasma and adrenal. Hypertension 1995 26 6 1173 1176 2-s2.0-0028883842
7. Bagrov A. Y., Shapiro J. I., Endogenous digitalis: pathophysiologic roles and therapeutic applications. Nature Clinical Practice Nephrology 2008 4 7 378 392 2-s2.0-46249110505 10.1038/ncpneph0848 (Pubitemid 351913708)
8. Hamlyn J. M., Blaustein M. P., Salt sensitivity, endogenous ouabain and hypertension. Current Opinion in Nephrology and Hypertension 2013 22 51 58
9. Manunta P., Stella P., Rivera R., Ciurlino D., Cusi D., Ferrandi M., Hamlyn J. M., Bianchi G., Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension. Hypertension 1999 34 3 450 456 2-s2.0-0032886736 (Pubitemid 29426762)
10. Schoner W., Bauer N., Müller-Ehmsen J., Krämer U., Hambarchian N., Schwinger R., Moeller H., Kost H., Weitkamp C., Schweitzer T., Kirch U., Neu H., Grünbaum E.-G., Ouabain as a mammalian hormone. Annals of the New York Academy of Sciences 2003 986 678 684 2-s2.0-0038578451 (Pubitemid 36584201)
11. Féraille E., Doucet A., Sodium-potassium-adenosinetriphosphatase- dependent sodium transport in the kidney: hormonal control. Physiological Reviews 2001 81 1 345 418 2-s2.0-0035133295 (Pubitemid 32096179)
12. Schoner W., Scheiner-Bobis G., Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. American Journal of Physiology. Cell Physiology 2007 293 2 C509 C536 2-s2.0-34547733409 10.1152/ajpcell.00098.2007 (Pubitemid 47235171)
13. Lingrel J. B., The physiological significance of the cardiotonic steroid/ouabain-binding site of the Na,K-ATPase. Annual Review of Physiology 2009 72 395 412 2-s2.0-77951883450 10.1146/annurev-physiol-021909-135725
14. Rodrigues-Mascarenhas S., de Oliveira A. D. S., Amoedo N. D., Affonso-Mitidieri O. R., Rumjanek F. D., Rumjanek V. M., Modulation of the immune system by ouabain. Annals of the New York Academy of Sciences 2009 1153 153 163 2-s2.0-60449103121 10.1111/j.1749-6632.2008.03969.x
15. de Paiva L. S., Costa K. M. D., Canto F. B. D., Cabral V. R., Fucs R., Nobrega A., Rumjanek V. M., Modulation of mature B cells in mice following treatment with ouabain. Immunobiology 2011 216 9 1038 1043 2-s2.0-79960838096 10.1016/j.imbio.2011.03.002
16. de Vasconcelos D. I. B., Leite J. A., Carneiro L. T., Piuvezam M. R., De Lima M. R. V., De Morais L. C. L., Rumjanek V. M., Rodrigues-Mascarenhas S., Anti-inflammatory and antinociceptive activity of ouabain in mice. Mediators of Inflammation 2011 2011 11 2-s2.0-80052649010 10.1155/2011/912925 912925
17. Jacob P. L., Leite J. A., Alves A. K., Rodrigues Y. K. S., Amorim F. M., Néris P. L. N., Oliveira M. R., Immunomodulatory activity of ouabain in Leishmania leishmania amazonensis-infected Swiss mice. Parasitology Research 2013 112 1313 1321
18. Foey A. D., Crawford A., Hall N. D., Modulation of cytokine production by human mononuclear cells following impairment of Na,K-ATPase activity. Biochimica et Biophysica Acta. Molecular Cell Research 1997 1355 1 43 49 2-s2.0-0031038353 10.1016/S0167-4889(96)00116-4 (Pubitemid 27043023)
19. Matsumori A., Ono K., Nishio R., Igata H., Shioi T., Matsui S., Furukawa Y., Iwasaki A., Nose Y., Sasayama S., Modulation of cytokine production and protection against lethal endotoxemia by the cardiac glycoside ouabain. Circulation 1997 96 5 1501 1506 2-s2.0-0343554056 (Pubitemid 27375343)
20. Matsumori A., Ono K., Nishio R., Nose Y., Sasayama S., Amlodipine inhibits the production of cytokines induced by ouabain. Cytokine 2000 12 3 294 297 2-s2.0-0033921236 10.1006/cyto.1999.0555 (Pubitemid 30449888)
21. Valente R. C., Nascimento C. R., Araujo E. G., Rumjanek V. M., mCD14 expression in human monocytes is downregulated by ouabain via transactivation of epithelial growth factor receptor and activation of p38 mitogen-activated protein kinase. Neuroimmunomodulation 2009 16 4 228 236 2-s2.0-64149131641 10.1159/000212383
22. Saha P., Geissmann F., Toward a functional characterization of blood monocytes. Immunology and Cell Biology 2011 89 1 2 4 2-s2.0-78651077510 10.1038/icb.2010.130
23. Farina C., Theil D., Semlinger B., Hohlfeld R., Meinl E., Distinct responses to monocytes to Toll-like receptor ligands and inflammatory cytokines. International Immunology 2004 16 6 799 809 2-s2.0-2942512621 10.1093/intimm/dxh083 (Pubitemid 38786521)
24. Bromley S. K., Iaboni A., Davis S. J., Whitty A., Green J. M., Shaw A. S., Weiss A., Dustin M. L., The immunological synapse and CD28-CD80 interactions. Nature Immunology 2001 2 12 1159 1166 2-s2.0-0035202768 10.1038/ni737 (Pubitemid 33130151)
25. Wollenberg A., Mommaas M., Oppel T., Schottdorf E.-M., Günther S., Moderer M., Expression and function of the mannose receptor CD206 on epidermal dendritic cells in inflammatory skin diseases. Journal of Investigative Dermatology 2002 118 2 327 334 2-s2.0-0036177227 10.1046/j.0022-202x.2001.01665. x (Pubitemid 34158489)
26. Auffray C., Sieweke M. H., Geissmann F., Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annual Review of Immunology 2009 27 669 692 2-s2.0-67649404131 10.1146/annurev.immunol.021908. 132557
27. Geissmann F., Manz M. G., Jung S., Sieweke M. H., Merad M., Ley K., Development of monocytes, macrophages, and dendritic cells. Science 2010 327 5966 656 661 2-s2.0-76249095169 10.1126/science.1178331
28. Tacke F., Randolph G. J., Migratory fate and differentiation of blood monocyte subsets. Immunobiology 2006 211 6-8 609 618 2-s2.0-33747358360 10.1016/j.imbio.2006.05.025
29. Grage-Griebenow E., Flad H.-D., Ernst M., Heterogeneity of human peripheral blood monocyte subsets. Journal of Leukocyte Biology 2001 69 1 11 20 2-s2.0-0035155787 (Pubitemid 32095112)
30. Gordon S., Taylor P. R., Monocyte and macrophage heterogeneity. Nature Reviews Immunology 2005 5 12 953 964 2-s2.0-28544446111 10.1038/nri1733 (Pubitemid 41746764)
31. Chow A., Brown B. D., Merad M., Studying the mononuclear phagocyte system in the molecular age. Nature Reviews Immunology 2011 11 11 788 798 2-s2.0-80355136629 10.1038/nri3087
32. Wikman A., Fagergren A., Johansson S. G. O., Lundahl J., Jacobson S. H., Monocyte activation and relationship to anti-proteinase 3 in acute vasculitis. Nephrology Dialysis Transplantation 2003 18 9 1792 1799 2-s2.0-0042384991 10.1093/ndt/gfg216 (Pubitemid 37098550)
33. Armah K. A., McGinnis K., Baker J., HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation. Clinical Infectious Diseases 2012 55 126 136
34. Kato M., Nell T. K., Fearnley D. B., McLellan A. D., Vuckovic S., Hart D. N. J., Expression of multilectin receptors and comparative FITC-dextran uptake by human dendritic cells. International Immunology 2000 12 11 1511 1519 2-s2.0-0033739798
35. Xie Z., Molecular mechanisms of Na/K-ATPase-mediated signal transduction. Annals of the New York Academy of Sciences 2003 986 497 503 2-s2.0-0038578665 (Pubitemid 36584154)
36. de Sá Lima L., Kawamoto E. M., Munhoz C. D., Ouabain activates NF κ B through an NMDA signaling pathway in cultured cerebellar cells. Neuropharmacology 2013 73 327 336
37. +-ATPase regulation. Fundamental and Clinical Pharmacology 2008 22 6 615 621 2-s2.0-57049098049 10.1111/j.1472-8206.2008.00620.x
38. +-ATPase: activation of phosphatidylinositide 3-kinase IA/Akt by ouabain is independent of src. Biochemistry 2013 52 9059 9067